MNPR
NASDAQ · Biotechnology
Monopar Therapeutics Inc
$71.42
+4.20 (+6.25%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
-42.2% upside
Low Target
$22.89
Average Target
$41.31
High Target
$45.20
Current Price
$71.42
Current
$71.42
$71.42
Target
$41.31
$41.31
$22.89
$41.31 avg
$45.20
Scenario Analysis
Bear Case
$22.89
-68.0%
Low target
Base Case
$41.31
-42.2%
Avg target
Bull Case
$45.20
+-36.7%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$124.82
-42.8% from high
52-Week Low
$50.07
+42.6% from low
Target vs 52W High
$41.31
-66.9% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.89
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |